Good morning, good afternoon and good evening. Last week, I sent a letter to all Member States requesting them to join the vaccine arm of the Act-Accelerator.
I am pleased to announce that as of today 172 countries are now engaging with the COVAX Global Vaccines Facility, which has both the largest and most diverse COVID-19 vaccine portfolio in the world.
At present there are nine vaccines that are part of this dynamic portfolio; which is constantly being reviewed and optimised to ensure access to the best possible range of products.
Even now, discussions are ongoing with four more producers. And a further nine vaccines are currently under evaluation for the longer term.